Parcion Private Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History

Parcion Private Wealth’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$282K	Buy	4,705 +126	+3%	+$7.94K	0.02%	450
2026 Q2	$262K	Sell	4,579 -2,768	-38%	-$152K	0.01%	422
2026 Q1	$415K	Buy	7,347 +270	+4%	+$15.7K	0.03%	276
2025 Q4	$421K	Buy	+7,077	New	+$385K	0.03%	263
2025 Q3	–	Sell	-7,038	Closed	-$387K	–	360
2025 Q2	$387K	Buy	7,038 +2,340	+50%	+$138K	0.03%	200
2025 Q1	$332K	Buy	+4,698	New	+$316K	0.03%	206

Other funds holding BMRN

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Parcion Private Wealth's BMRN Position: Q3 2026 in Review

Parcion Private Wealth increased its BioMarin Pharmaceuticals (BMRN) stake by 2.8% in Q3 2026, buying an estimated $7.94K and bringing the position to 4,705 shares worth $282K. The position accounts for 0.02% of the portfolio, ranked #450.

Parcion Private Wealth first reported a position in BMRN in Q1 2025 and has held it in 6 quarters since. The position peaked at $421K in Q4 2025. 434 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

Parcion Private Wealth held 4,705 shares of BioMarin Pharmaceuticals worth $282K as of Q3 2026.
Parcion Private Wealth bought 126 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $7.94K.
BioMarin Pharmaceuticals made up 0.02% of Parcion Private Wealth's portfolio in Q3 2026, its #450 holding.
Parcion Private Wealth first reported a position in BioMarin Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Parcion Private Wealth's BioMarin Pharmaceuticals position peaked at $421K in Q4 2025.
434 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Parcion Private Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.